The Latest Breaking News from Omicron

The Swindon-based retailer said it had seen a recovery across all its travel markets despite the impact of the Omicron variant

The issue isn't around safety, but instead messaging and vaccine effectiveness

The FDA has cleared Sorrento Therapeutics Inc's (NASDAQ:SRNE) investigational new drug application (IND) for intravenous (IV) STI-9167 (COVISHIELD) to study the safety and pharmacokinetics in healthy volunteers.  STI-9167 is the IV formulation of the intranasal STI-9199 neutralizing antibody. Also Read: Sorrento To Start Late-Stage Trial Of Abivertinib In Critically-Ill COVID-19 Patients. The Phase 1 study…

Poland can compromise with Moderna Inc (NASDAQ:MRNA) on increasing the flexibility of COVID-19 vaccine contracts, Reuters reported citing the health minister, striking an upbeat tone after initial talks with the company. Poland has said it will not take or pay for more doses of the COVID-19 vaccine under the European Union's supply contract.  Reuters…

Business & Investing: Fear returns to markets as investors turn bearish, and Kiwi dollar at three-month low against US dollar

The US has just approved a new COVID-19 breathalyser test that promises to deliver results within minutes, with no nasal swabs required. Scientists say it could help safeguard big gatherings from becoming superspreader events, but there are still a few kinks to iron out.

There is growing concern about a new Covid subvariant Omicron XE, which was first identified in January, according to the World Health Organisation

BOSTON — The closely monitored Boston-area COVID-19 wastewater data has started falling in the past few days, sending an encouraging signal to local infectious disease experts who are “cautiously optimistic” about this virus drop.

Fainting and fatigue may signal onset of Omicron, experts say